Literature DB >> 8881944

Quality of life in patients undergoing bacille Calmette-Guérin therapy for superficial bladder cancer.

D Mack1, J Frick.   

Abstract

OBJECTIVE: To determine the impact of post-operative education about bladder cancer and topical immunotherapy on the physical, psychological and social well-being of patients with superficial bladder cancer. PATIENTS AND METHODS: Eighty-five patients (mean age 59 years, range 26-85, 64 men and 21 women) receiving topical immunotherapy were questioned during the initial cycle of treatment and during maintenance therapy with bacille Calmette-Guérin (BCG). Patients completed a questionnaire on their quality of life when they commenced treatment and twice more during maintenance therapy.
RESULTS: Psychological distress and physical symptoms were intense when the diagnosis of bladder cancer was revealed to the patients, despite the knowledge that this cancer is usually curable. The overall quality of life, condition of health and sexual activity were mostly only moderate, were poor during initial therapy and better during 3-monthly maintenance therapy.
CONCLUSION: In general, the quality of life of these patients is characterized by the disruption of their lifestyle and marked by change in their circumstances. It is the responsibility of the urologist to take the necessary time to educate, comfort and motivate such patients with superficial bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881944     DOI: 10.1046/j.1464-410x.1996.00134.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  8 in total

Review 1.  Optimal treatment of non-muscle invasive urothelial carcinoma including perioperative management revisited.

Authors:  Matthew J Pagano; Gina Badalato; James M McKiernan
Journal:  Curr Urol Rep       Date:  2014-11       Impact factor: 3.092

Review 2.  Quality of life aspects of bladder cancer: a review of the literature.

Authors:  M F Botteman; C L Pashos; R S Hauser; B L Laskin; A Redaelli
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

3.  Surveillance and treatment of non-muscle-invasive bladder cancer in the USA.

Authors:  Daniel A Barocas; Denise R Globe; Danielle C Colayco; Ahunna Onyenwenyi; Amanda S Bruno; Thomas J Bramley; Rachel J Spear
Journal:  Adv Urol       Date:  2012-05-10

4.  Erectile dysfunction in nonmuscle-invasive bladder cancer patients before and after transurethral resection (TUR) of bladder tumor in China.

Authors:  Peng Guo; Yu Wang; Yun-Feng Xie; Tian-Bing Lv
Journal:  Asian J Androl       Date:  2022 Sep-Oct       Impact factor: 3.054

Review 5.  Impact of Effective Intravesical Therapies on Quality of Life in Patients with Non-Muscle Invasive Bladder Cancer: A Systematic Review.

Authors:  John W Yuen; Ricky W Wu; Shirley S Ching; Chi-Fai Ng
Journal:  Int J Environ Res Public Health       Date:  2022-08-30       Impact factor: 4.614

6.  Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer.

Authors:  Piyus K Agarwal; Ashish M Kamat
Journal:  Indian J Urol       Date:  2008-01

Review 7.  Pursuing Quality in the Application of Bladder Cancer Quality of Life Research.

Authors:  N E Mohamed; F Gilbert; C T Lee; J Sfakianos; C Knauer; R Mehrazin; H Badr; D Wittmann; T Downs; D Berry; B Given; P Wiklund; G Steineck
Journal:  Bladder Cancer       Date:  2016-04-27

8.  Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer-a systematic review.

Authors:  Arvind Nayak; Joanne Cresswell; Paramananthan Mariappan
Journal:  Transl Androl Urol       Date:  2021-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.